🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Motor fluctuations are identified as the most challenging symptoms by parki...
Status
Not Yet Recruiting
Location
CHU Toulouse
Start Date
2025-05-01
Trial ID
NCT06817200
Treatments Being Tested
This study is a multi-center, real-word clinical trial. The purpose of this...
Status
Unknown
Location
Beijing Children's Hospital, Capital Medical University
Start Date
2021-07-02
Trial ID
NCT05274035
Treatments Being Tested
The purpose of this study is to examine whether a low dose of CBD+THC will ...
Status
Terminated
Location
University Hospital Campus, London Health Sciences Centre
Start Date
2019-01-10
Trial ID
NCT03808935
Treatments Being Tested
One-lung ventilation (OLV) is routinely used during thoracic surgery to fac...
Status
Completed
Location
Gazi University
Start Date
2022-08-05
Trial ID
NCT07359833
Treatments Being Tested
The purpose of this study is to evaluate and compare the efficacy and safet...
Status
Completed
Location
Multiple Locations
Start Date
2006-02
Trial ID
NCT00276458
Treatments Being Tested
The primary purpose of this study is to evaluate the effect of the up-titra...
Status
Completed
Location
SGS Clinical Pharmacology Unit (located in ZNA Stuivenberg)
Start Date
2019-03-20
Trial ID
NCT03882255
Treatments Being Tested
The goal of this clinical trial is to evaluate the safety, tolerability, ph...
Status
Recruiting
Location
The First Affiliated Hospital, School of Medicine, Zhejiang University
Start Date
2024-11-03
Trial ID
NCT07014449
Treatments Being Tested
Cirrhosis is a form of advanced liver disease that can lead to serious comp...
Status
Recruiting
Location
Cleveland Clinic Main Campus
Start Date
2025-12-17
Trial ID
NCT07058155
VK-2019-001 is a 1/2a trial of the oral EBNA-1 targeting agent VK-2019 in p...
Status
Terminated
Location
Stanford University, School of Medicine, Stanford Cancer Institute
Start Date
2019-04-04
Trial ID
NCT03682055
Treatments Being Tested
The purpose of this study is to assess secukinumab high dose (every 2 weeks...
Status
Completed
Location
Novartis Investigative Site
Start Date
2018-06-25
Trial ID
NCT03504852
Treatments Being Tested